{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:57:51Z","timestamp":1740135471509,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801511","31701102","81702800","81502438"],"award-info":[{"award-number":["81801511","31701102","81702800","81502438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2013CB945201"],"award-info":[{"award-number":["2013CB945201"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education Science and technology research","award":["213008A"],"award-info":[{"award-number":["213008A"]}]},{"name":"Ministry of Education fund innovation team","award":["IRT 13101"],"award-info":[{"award-number":["IRT 13101"]}]},{"name":"Foundation for Special Professor of Liaoning Province for Yue Zhao","award":["the 5th batch"],"award-info":[{"award-number":["the 5th batch"]}]},{"name":"Key Laboratory Grant of Education Department of Liaoning Province","award":["LS201602"],"award-info":[{"award-number":["LS201602"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12905-019-0718-1","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T10:02:50Z","timestamp":1548410570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expression and potential role of SNF5 in endometrial carcinoma"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-7907","authenticated-orcid":false,"given":"Shiying","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"718_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"718_CR2","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.3802\/jgo.2018.29.e7","volume":"29","author":"X Jiang","year":"2018","unstructured":"Jiang X, Tang H, Chen T. Epidemiology of gynecologic cancers in China. J Gynecol Oncol. 2018;29:e7.","journal-title":"J Gynecol Oncol"},{"key":"718_CR3","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/sj.onc.1209986","volume":"26","author":"YF Wong","year":"2007","unstructured":"Wong YF, Cheung TH, Lo KW, Yim SF, Siu NS, Chan SC, et al. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene. 2007;26:1971\u201382.","journal-title":"Oncogene"},{"key":"718_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"718_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67\u201373.","journal-title":"Nature"},{"key":"718_CR6","doi-asserted-by":"crossref","unstructured":"Arend RC, Jones BA, Martinez A, Goodfellow P. Endometrial cancer: molecular markers and management of advanced stage disease. Gynecol Oncol. 2018.","DOI":"10.1016\/j.ygyno.2018.05.015"},{"key":"718_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","volume":"18","author":"BG Wilson","year":"2010","unstructured":"Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, et al. Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation. Cancer Cell. 2010;18:316\u201328.","journal-title":"Cancer Cell"},{"key":"718_CR8","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1038\/onc.2010.159","volume":"29","author":"Y Xu","year":"2010","unstructured":"Xu Y, Yan W, Chen X. SNF5, a core component of the SWI\/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E. Oncogene. 2010;29:4090\u2013100.","journal-title":"Oncogene"},{"key":"718_CR9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/ng.2805","volume":"45","author":"RS Lee","year":"2013","unstructured":"Lee RS, Roberts CW. Linking the SWI\/SNF complex to prostate cancer. Nat Genet. 2013;45:1268\u20139.","journal-title":"Nat Genet"},{"key":"718_CR10","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/0008-5472.CAN-09-1922","volume":"70","author":"Y Kuwahara","year":"2010","unstructured":"Kuwahara Y, Charboneau A, Knudsen ES, Weissman BE. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1\/WAF1)-dependent mechanism. Cancer Res. 2010;70:1854\u201365.","journal-title":"Cancer Res"},{"key":"718_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4161\/cc.5.6.2579","volume":"5","author":"CG Sansam","year":"2006","unstructured":"Sansam CG, Roberts CW. Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation. Cell Cycle. 2006;5:621\u20134.","journal-title":"Cell Cycle"},{"key":"718_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ncb3378","volume":"18","author":"P Galanos","year":"2016","unstructured":"Galanos P, Vougas K, Walter D, Polyzos A, Maya-Mendoza A, Haagensen EJ, et al. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing. Nat Cell Biol. 2016;18:777\u201389.","journal-title":"Nat Cell Biol"},{"key":"718_CR13","doi-asserted-by":"crossref","first-page":"81942","DOI":"10.18632\/oncotarget.17286","volume":"8","author":"S Heng","year":"2017","unstructured":"Heng S, Evans J, Salamonsen LA, Jobling TW, Nie G. The significance of post-translational removal of alpha-DG-N in early stage endometrial cancer development. Oncotarget. 2017;8:81942\u201352.","journal-title":"Oncotarget"},{"key":"718_CR14","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.1093\/nar\/gkw472","volume":"44","author":"S Sun","year":"2016","unstructured":"Sun S, Zhong X, Wang C, Sun H, Wang S, Zhou T, et al. BAP18 coactivates androgen receptor action and promotes prostate cancer progression. Nucleic Acids Res. 2016;44:8112\u201328.","journal-title":"Nucleic Acids Res"},{"key":"718_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1158\/1541-7786.MCR-12-0390","volume":"11","author":"Y Kuwahara","year":"2013","unstructured":"Kuwahara Y, Wei D, Durand J, Weissman BE. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI\/SNF complexes and RNAPII to the transcription start site of their promoters. Mol Cancer Res. 2013;11:251\u201360.","journal-title":"Mol Cancer Res"},{"key":"718_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","volume":"127","author":"C Korch","year":"2012","unstructured":"Korch C, Spillman MA, Jackson TA, Jacobsen BM, Murphy SK, Lessey BA, et al. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol Oncol. 2012;127:241\u20138.","journal-title":"Gynecol Oncol"},{"key":"718_CR17","first-page":"2977","volume":"38","author":"J Phelippeau","year":"2018","unstructured":"Phelippeau J, Rouzier R, Koskas M. Adherence to guidelines during follow-up of endometrial Cancer: analysis of French health insurance database. Anticancer Res. 2018;38:2977\u201382.","journal-title":"Anticancer Res"},{"key":"718_CR18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ijrobp.2018.04.049","volume":"101","author":"MM Harkenrider","year":"2018","unstructured":"Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, et al. Multi-institutional analysis of vaginal brachytherapy alone for women with stage II endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2018;101:1069\u201377.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"718_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/AOG.0000000000002057","volume":"129","author":"SJ Jordan","year":"2017","unstructured":"Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, et al. Breastfeeding and endometrial Cancer risk: an analysis from the epidemiology of endometrial Cancer consortium. Obstet Gynecol. 2017;129:1059\u201367.","journal-title":"Obstet Gynecol"},{"key":"718_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/path.4633","volume":"238","author":"AN Karnezis","year":"2016","unstructured":"Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D'Angelo E, et al. Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. J Pathol. 2016;238:389\u2013400.","journal-title":"J Pathol"},{"key":"718_CR21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/ar.23357","volume":"299","author":"H Sun","year":"2016","unstructured":"Sun H, Zhong X, Wang C, Wang S, Lin L, Zou R, et al. SNF5 is involved in suppression of hepatocellular carcinoma progression via TGF-Beta 1 signaling. Anat Rec (Hoboken). 2016;299:869\u201377.","journal-title":"Anat Rec (Hoboken)"},{"key":"718_CR22","doi-asserted-by":"crossref","unstructured":"Bai M, Yang L, Liao H, Liang X, Xie B, Xiong J, et al. Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism. Oncogene. 2018.","DOI":"10.1038\/s41388-018-0360-7"},{"key":"718_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/emboj\/21.1.31","volume":"21","author":"E Craig","year":"2002","unstructured":"Craig E, Zhang ZK, Davies KP, Kalpana GV. A masked NES in INI1\/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. EMBO J. 2002;21:31\u201342.","journal-title":"EMBO J"},{"key":"718_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/modpathol.2010.71","volume":"23","author":"K Kohashi","year":"2010","unstructured":"Kohashi K, Oda Y, Yamamoto H, Tamiya S, Matono H, Iwamoto Y, et al. Reduced expression of SMARCB1\/INI1 protein in synovial sarcoma. Mod Pathol. 2010;23:981\u201390.","journal-title":"Mod Pathol"},{"key":"718_CR25","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1158\/0008-5472.CAN-04-3050","volume":"65","author":"P Modena","year":"2005","unstructured":"Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, et al. SMARCB1\/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005;65:4012\u20139.","journal-title":"Cancer Res"},{"key":"718_CR26","doi-asserted-by":"publisher","first-page":"17745","DOI":"10.1073\/pnas.0509014102","volume":"102","author":"MS Isakoff","year":"2005","unstructured":"Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, et al. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A. 2005;102:17745\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"718_CR27","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1128\/MCB.26.7.2661-2674.2006","volume":"26","author":"A Klochendler-Yeivin","year":"2006","unstructured":"Klochendler-Yeivin A, Picarsky E, Yaniv M. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5\/Ini1 subunit of the SWI\/SNF chromatin remodeling complex. Mol Cell Biol. 2006;26:2661\u201374.","journal-title":"Mol Cell Biol"},{"key":"718_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400\u201314.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-019-0718-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-019-0718-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-019-0718-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T01:17:08Z","timestamp":1606180628000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-019-0718-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1186\/s12905-019-0718-1","relation":{},"ISSN":["1472-6874"],"issn-type":[{"type":"electronic","value":"1472-6874"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"16 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental design of genomic and expression studies was reviewed and approved by the Medical Ethics Committee of China Medical University (2018PS495K). Each participant provided written informed consent to be included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"16"}}